miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1

被引:85
作者
Fan, Song [1 ,2 ]
Chen, Wei-Xiong [2 ]
Lv, Xiao-Bin [3 ]
Tang, Qiong-Lan [4 ]
Sun, Li-Juan [5 ]
Liu, Bo-Du [5 ]
Zhong, Jiang-Long [2 ]
Lin, Zhao-Yu [2 ]
Wang, You-Yuan [2 ]
Li, Qun-Xing [2 ]
Yu, Xin [2 ]
Zhang, Han-Qing [2 ]
Li, Yi-Lin [6 ]
Wen, Bin [7 ]
Zhang, Zhang [8 ]
Chen, Wei-Liang [2 ]
Li, Jin-Song [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Oral & Maxillofacial Surg, Guangzhou 510120, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangzhou 510120, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Pathol, Guangzhou 510120, Guangdong, Peoples R China
[5] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Breast Tumor Ctr, Guangzhou 510120, Guangdong, Peoples R China
[6] Xaverian Bros High Sch, Westwood, MA 02090 USA
[7] Affiliated Hosp, North Sichuan Med Coll, Dept Pathol, Nanchang 637600, Peoples R China
[8] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610041, Peoples R China
基金
中国国家自然科学基金;
关键词
Mitochondrial fission; Cisplatin sensitivity; miR-483-5p; FIS1; Tongue squamous cell carcinoma; DYNAMICS; RESISTANCE; APOPTOSIS; FLUOROURACIL; CHEMOTHERAPY; MECHANISMS; FUSION; TRIAL; HEAD; DRP1;
D O I
10.1016/j.canlet.2015.03.045
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mitochondria play an important role in the initiation of apoptosis. However, whether cisplatin can induce apoptosis by initiating a mitochondrial fission pathway and the mechanism underlying this effect remain poorly understood. In this study, we show that the mitochondrial fission protein FIS1 is upregulated upon cisplatin treatment in tongue squamous cell carcinoma (TSCC) cells. FIS1 knockdown can attenuate mitochondrial fission and cisplatin sensitivity. We found that FIS1 is a direct target of miR-483-5p and that miR-483-5p can inhibit mitochondrial fission and cisplatin sensitivity in vitro and in vivo. Furthermore, we found that miR-483-5p and FIS1 are significantly associated with cisplatin sensitivity and with overall survival in patients with TSCC in a retrospective analysis of multiple centers. This study revealed that a novel mitochondrial fission pathway composed of miR-483-5p and FIS1 regulates cisplatin sensitivity. The modulation of miR-483-5p and FIS1 levels may provide a new approach for increasing cisplatin sensitivity. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:183 / 191
页数:9
相关论文
共 33 条
[1]   Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549) [J].
Bian, Hai-Bo ;
Pan, Xuan ;
Yang, Jin-Song ;
Wang, Zhao-Xia ;
De, Wei .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2011, 30
[2]   Fragmented mitochondria are sensitized to Bax insertion and activation during apoptosis [J].
Brooks, Craig ;
Cho, Sung-Gyu ;
Wang, Cong-Yi ;
Yang, Tianxin ;
Dong, Zheng .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2011, 300 (03) :C447-C455
[3]   Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models [J].
Brooks, Craig ;
Wei, Qingqing ;
Cho, Sung-Gyu ;
Dong, Zheng .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (05) :1275-1285
[4]   Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling [J].
Cipolat, Sara ;
Rudka, Tomasz ;
Hartmann, Dieter ;
Costa, Veronica ;
Serneels, Lutgarde ;
Craessaerts, Katleen ;
Metzger, Kristine ;
Frezza, Christian ;
Annaert, Wim ;
D'Adamio, Luciano ;
Derks, Carmen ;
Dejaegere, Tim ;
Pellegrini, Luca ;
D'Hooge, Rudi ;
Scorrano, Luca ;
De Strooper, Bart .
CELL, 2006, 126 (01) :163-175
[5]   The role of microRNA in the response to cisplatin treatment [J].
Drayton, Ross M. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 :821-825
[6]   An Improved Quantitative Approach for the Assessment of Mitochondrial Fragmentation in Chemoresistant Ovarian Cancer Cells [J].
Farrand, Lee ;
Kim, Ji Young ;
Im-Aram, Akechai ;
Suh, Jeong-Yong ;
Lee, Hyong Joo ;
Tsang, Benjamin K. .
PLOS ONE, 2013, 8 (09)
[7]   Molecular mechanisms of cisplatin resistance [J].
Galluzzi, L. ;
Senovilla, L. ;
Vitale, I. ;
Michels, J. ;
Martins, I. ;
Kepp, O. ;
Castedo, M. ;
Kroemer, G. .
ONCOGENE, 2012, 31 (15) :1869-1883
[8]   Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): An intergroup trial of the eastern cooperative oncology group [J].
Gibson, MK ;
Li, Y ;
Murphy, B ;
Hussain, MHA ;
DeConti, RC ;
Ensley, J ;
Forastiere, AA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3562-3567
[9]   Mechanisms of resistance to cisplatin [J].
Kartalou, M ;
Essigmann, JM .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2001, 478 (1-2) :23-43
[10]   Arsenic trioxide enhances the cytotoxic effect of cisplatin in head and neck squamous cell carcinoma cell lines [J].
Kotowski, Ulana ;
Heiduschka, Gregor ;
Brunner, Markus ;
Erovic, Boban M. ;
Martinek, Helga ;
Thurnher, Dietmar .
ONCOLOGY LETTERS, 2012, 3 (06) :1326-1330